Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
NANOCOVER Aktie jetzt für 0€ handeln |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
FORMYCON | 22,250 | +0,45 % | EQS-News: Formycon AG: Formycon und Fresenius Kabi geben FDA-Zulassung von FYB202/Otulfi® (Ustekinumab-aauz) als austauschbares Biosimilar ("interchangeable") bekannt | EQS-News: Formycon AG
/ Schlagwort(e): Sonstiges
Formycon und Fresenius Kabi geben FDA-Zulassung von FYB202/Otulfi® (Ustekinumab-aauz) als austauschbares Biosimilar ("interchangeable")... ► Artikel lesen | |
ONTO INNOVATION | 81,00 | -4,14 % | ONTO INNOVATION INC. - 8-K, Current Report | ||
KOPIN | 1,183 | -3,66 % | KOPIN CORP - 10-K/A, Annual Report | ||
SOLESENCE | 3,790 | -1,69 % | Solésence, Inc.: Solésence Announces Uplisting to Nasdaq | Trading set to begin Tuesday, April 8 under new ticker "SLSN" ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB: NANX), a leader in scientifically-driven health care solutions... ► Artikel lesen | |
GAUZY | 8,410 | +2,62 % | GAUZY LTD: Gauzy Announces Minimal to No Impact on Business with Its U.S. Customers Amid United States New Tariff Policy on Imports | Gauzy's Long-Established 20,000 SqFt Production Facility in Florida, Originally Designated to Support U.S. Aeronautics Customers, Already Serves All Company Divisions, Including Architecture, Automotive... ► Artikel lesen | |
FENDX TECHNOLOGIES | 0,046 | -1,29 % | FendX Technologies Inc.: FendX Announces Share Issuance Pursuant to IP License Agreement | Oakville, Ontario--(Newsfile Corp. - May 5, 2025) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or "FendX"), a nanotechnology company developing surface protection... ► Artikel lesen | |
GOMSPACE | 1,084 | +21,12 % | GomSpace Group AB: GomSpace reports positive net profit in Q1 2025 | GomSpace releases its Q1 2025 trading statement and reports a strong revenue growth, positive operational EBITDA and a positive net profit in the first quarter.
FIRST QUARTER OF 2025
Order intake... ► Artikel lesen | |
NANOVIRICIDES | 1,330 | +2,31 % | The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides' Dr. Diwan | SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the "Company"), comments on the new COVID Vaccine policy adopted by the US FDA.The... ► Artikel lesen | |
VEECO INSTRUMENTS | 17,000 | 0,00 % | VEECO INSTRUMENTS INC - S-8, Securities to be offered to employees in employee benefit plans | ||
OBDUCAT | 0,048 | -5,88 % | XFRA CAPITAL ADJUSTMENT INFORMATION - 14.03.2025 | Das Instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY wird cum Kapitalmassnahme gehandelt am 14.03.2025 und ex Kapitalmassnahme am 17.03.2025 The instrument OBD SE0000514705 OBDUCAT AB B SK 8 EQUITY... ► Artikel lesen | |
ACACIA RESEARCH | 3,160 | -3,07 % | ACACIA RESEARCH CORP - 8-K, Current Report | ||
ADVANCE ZINCTEK | 0,428 | 0,00 % | ADVANCE ZINCTEK LIMITED: Business Update | ||
LEHNER INVESTMENTS | 0,035 | 0,00 % | EQS-Adhoc: LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet | EQS-Ad-hoc: LEHNER INVESTMENTS AG / Schlagwort(e): Rechtssache
LEHNER INVESTMENTS AG: Sonderprüfung gerichtlich angeordnet
04.04.2025 / 18:00 CET/CEST
Veröffentlichung einer Insiderinformation... ► Artikel lesen | |
NANOFOCUS | 0,610 | 0,00 % | NanoFocus schließt Kapitalerhöhung ab | Die NanoFocus AG hat die beschlossene Kapitalerhöhung gegen Sach- und Bareinlagen durchgeführt. Insgesamt wurden 6.021.664 neue Aktien zu je 1,00 Euro ausgegeben. Davon gingen 4.276.884 Aktien an die... ► Artikel lesen | |
RIBER | 2,330 | +3,56 % | RIBER reports solid growth in sales and earnings in 2024 | RIBER reports solid growth in sales and earnings in 2024 Revenues: €41.2m (+5%)Income from ordinary operations: €4.5m, representing 11% of revenues Net income: €4.1m (+21%)Proposed payout of €0.08... ► Artikel lesen |